Researchers at Duke University have shown that blocking an enzyme involved in iron regulation not only kills multiple myeloma cancer cells, but also increases the effectiveness of current therapies against the disease. Their research was published on September 12 in the journal Blood.
This article was originally published on MedicalXpress.com